Streetbeat News

Partnerships

MLNK

MeridianLink, Inc. (NYSE:MLNK) has announced a new integration with Experian, providing lenders with real-time access to verified income and employment information. The integration of Experian Verify with MeridianLink Consumer and Mortgage Credit Link will provide customers with enhanced capabilities that deliver a seamless digital lending experience. This move is expected to reduce risk, accelerate conversion, save money, and maintain compliance with the Fair Credit Reporting Act.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 1:08 pm

BLRX

SNTI

Senti Bio announced multiple data presentations at the Society for Immunotherapy of Cancer Annual Meeting. The presentations include new preclinical data with BlueRock Therapeutics and showcase Senti Bio's proprietary Gene Circuit platform.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 1:07 pm

OCUL

AffaMed Therapeutics announced positive top-line results from a real-world study in China evaluating the safety and efficacy of DEXTENZA in patients after cataract surgery. The trial met its primary and secondary endpoints, demonstrating a significant reduction of ocular inflammation and pain. AffaMed has a licensing agreement with Ocular Therapeutix, Inc. (NASDAQ: OCUL) for the development and commercialization of DEXTENZA in Greater China, South Korea, and certain ASEAN markets.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 1:07 pm

BLRX

BioLineRx Ltd. (BLRX) has entered into an exclusive license agreement with Guangzhou Gloria Biosciences Co., Ltd. (GloriaBio) for the development of motixafortide across all indications in Asia. The agreement includes a $15 million upfront payment, an equity investment of $14.6 million, up to $50 million in potential development and regulatory milestones, and up to $200 million in potential commercial milestones. The deal was facilitated by M.S.Q. Ventures.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 1:05 pm

CDIO

Cardio Diagnostics Holdings, Inc (NASDAQ:CDIO) has been awarded an Innovation Technology contract by Vizient, Inc., the largest provider-driven healthcare performance improvement company in the US. The contract is for Cardio Diagnostics' AI-driven molecular heart disease tests, Epi+Gen CHD and PrecisionCHD, which identify epigenetic and genetic biomarkers in patients at risk of coronary heart disease. The contract will be effective from November 1.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 1:05 pm

JNVR

Janover Inc (NASDAQ:JNVR) and Xchange.Loans Inc have announced a strategic partnership to expand their commercial loan offerings. The partnership will allow both companies to access each other's loan products, enabling cross-platform sales and an enhanced customer experience. Janover's platform includes 64% of the largest 100 credit unions and nearly 10% of all FDIC-insured banks in America.

Portfolio Pulse from Anusuya Lahiri

October 31, 2023 | 1:01 pm

ICE

Argyle has partnered with ICE Mortgage Technology to provide real-time income and employment verification data to the Encompass platform. This partnership aims to bring cost-effective solutions to the platform.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 1:01 pm

JNVR

Janover is planning to broaden its offerings by providing access to another company's loan products, enabling cross-platform sales and an enhanced customer experience.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 1:01 pm

ABT

STXS

Abbott Laboratories (ABT) and Stereotaxis (STXS) have announced that their integrated technologies have been used for the first time in procedures in the United States. This collaboration could potentially lead to improved patient outcomes in complex cardiac procedures.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 1:00 pm

JNVR

Janover Ventures (JNVR) has announced a strategic partnership with Xchange.Loans to capitalize on market dislocations. The partnership aims to leverage the strengths of both companies to take advantage of opportunities arising from market volatility.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 1:00 pm